These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 33240412)
1. Blockade of TRIM59 enhances esophageal cancer cell chemosensitivity to cisplatin by upregulating p53. Liu R; Li H; Xu Y; Li X; Guo X; Shi J; Cui Y; Wang Z; Liu J Oncol Lett; 2021 Jan; 21(1):6. PubMed ID: 33240412 [TBL] [Abstract][Full Text] [Related]
2. TRIM59 is up-regulated in gastric tumors, promoting ubiquitination and degradation of p53. Zhou Z; Ji Z; Wang Y; Li J; Cao H; Zhu HH; Gao WQ Gastroenterology; 2014 Nov; 147(5):1043-54. PubMed ID: 25046164 [TBL] [Abstract][Full Text] [Related]
3. TRIM59-mediated ferroptosis enhances neuroblastoma development and chemosensitivity through p53 ubiquitination and degradation. Liu Y; Jiang N; Chen W; Zhang W; Shen X; Jia B; Chen G Heliyon; 2024 Feb; 10(4):e26014. PubMed ID: 38434050 [TBL] [Abstract][Full Text] [Related]
4. TRIM59 as a novel molecular biomarker to predict the prognosis of patients with NSCLC. Lou M; Gao Z; Zhu T; Mao X; Wang Y; Yuan K; Tong J Oncol Lett; 2020 Feb; 19(2):1400-1408. PubMed ID: 31966070 [TBL] [Abstract][Full Text] [Related]
5. TRIM59 Is a Novel Marker of Poor Prognosis and Promotes Malignant Progression of Ovarian Cancer by Inducing Annexin A2 Expression. Wang Y; Zhou Z; Wang X; Zhang X; Chen Y; Bai J; Di W Int J Biol Sci; 2018; 14(14):2073-2082. PubMed ID: 30585270 [TBL] [Abstract][Full Text] [Related]
6. TRIM59 overexpression correlates with poor prognosis and contributes to breast cancer progression through AKT signaling pathway. Liu Y; Dong Y; Zhao L; Su L; Diao K; Mi X Mol Carcinog; 2018 Dec; 57(12):1792-1802. PubMed ID: 30175868 [TBL] [Abstract][Full Text] [Related]
7. TRIM59 is a novel potential prognostic biomarker in patients with non-small cell lung cancer: A research based on bioinformatics analysis. Hao L; Du B; Xi X Oncol Lett; 2017 Aug; 14(2):2153-2164. PubMed ID: 28789440 [TBL] [Abstract][Full Text] [Related]
8. [Expression of TRIM59 in Non-small Cell Lung Cancer and Its Correlation with Prognosis]. Tian H; Zhang D; Xu R; Qin Y; Lan Y; Jiao W; Han Y Zhongguo Fei Ai Za Zhi; 2020 Jan; 23(1):21-28. PubMed ID: 31948534 [TBL] [Abstract][Full Text] [Related]
9. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway. Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X Gene; 2019 May; 698():50-60. PubMed ID: 30822475 [TBL] [Abstract][Full Text] [Related]
10. SLC35F2-SYVN1-TRIM59 axis critically regulates ferroptosis of pancreatic cancer cells by inhibiting endogenous p53. Che B; Du Y; Yuan R; Xiao H; Zhang W; Shao J; Lu H; Yu Y; Xiang M; Hao L; Zhang S; Du X; Liu X; Zhou W; Wang K; Chen L Oncogene; 2023 Oct; 42(44):3260-3273. PubMed ID: 37740007 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of tripartite motif 59 and its diagnostic utility in benign bowel diseases and colorectal cancer. Dahpy MA; Salama RHM; Kamal AA; El-Deek HE; AbdelMotaleb AA; Abd-El-Rehim AS; Hassan EA; Alsanory AA; Saad MM; Ali M J Biochem Mol Toxicol; 2022 Jul; 36(7):e23065. PubMed ID: 35377964 [TBL] [Abstract][Full Text] [Related]
12. Knockdown of tripartite motif-59 inhibits the malignant processes in human colorectal cancer cells. Wu W; Chen J; Wu J; Lin J; Yang S; Yu H Oncol Rep; 2017 Oct; 38(4):2480-2488. PubMed ID: 28849218 [TBL] [Abstract][Full Text] [Related]
13. Knockdown of tripartite motif 59 (TRIM59) inhibits tumor growth in prostate cancer. Lin WY; Wang H; Song X; Zhang SX; Zhou PS; Sun JM; Li JS Eur Rev Med Pharmacol Sci; 2016 Dec; 20(23):4864-4873. PubMed ID: 27981550 [TBL] [Abstract][Full Text] [Related]
14. TRIM59 Promotes the Proliferation and Migration of Non-Small Cell Lung Cancer Cells by Upregulating Cell Cycle Related Proteins. Zhan W; Han T; Zhang C; Xie C; Gan M; Deng K; Fu M; Wang JB PLoS One; 2015; 10(11):e0142596. PubMed ID: 26599082 [TBL] [Abstract][Full Text] [Related]
15. TRIM59 is a key regulator of growth and migration inrenal cell carcinoma. Hu SH; Zhao MJ; Wang WX; Xu CW; Wang GD Cell Mol Biol (Noisy-le-grand); 2017 May; 63(5):68-74. PubMed ID: 28719348 [TBL] [Abstract][Full Text] [Related]
16. TRIM59 facilitates the proliferation of colorectal cancer and promotes metastasis via the PI3K/AKT pathway. Sun Y; Ji B; Feng Y; Zhang Y; Ji D; Zhu C; Wang S; Zhang C; Zhang D; Sun Y Oncol Rep; 2017 Jul; 38(1):43-52. PubMed ID: 28534983 [TBL] [Abstract][Full Text] [Related]
17. TRIM59 promotes cell proliferation, migration and invasion in human hepatocellular carcinoma cells. Sun G; Sui X; Han D; Gao J; Liu Y; Zhou L Pharmazie; 2017 Nov; 72(11):674-679. PubMed ID: 29442042 [TBL] [Abstract][Full Text] [Related]
18. Knockdown of MAML1 inhibits proliferation and induces apoptosis of T-cell acute lymphoblastic leukemia cells through SP1-dependent inactivation of TRIM59. Cheng H; Chen L; Hu X; Qiu H; Xu X; Gao L; Tang G; Zhang W; Wang J; Yang J; Huang C J Cell Physiol; 2019 Apr; 234(4):5186-5195. PubMed ID: 30370525 [TBL] [Abstract][Full Text] [Related]
19. TRIM59 promotes tumor growth in hepatocellular carcinoma and regulates the cell cycle by degradation of protein phosphatase 1B. Ying H; Ji L; Xu Z; Fan X; Tong Y; Liu H; Zhao J; Cai X Cancer Lett; 2020 Mar; 473():13-24. PubMed ID: 31875525 [TBL] [Abstract][Full Text] [Related]
20. TRIM59 is upregulated and promotes cell proliferation and migration in human osteosarcoma. Liang J; Xing D; Li Z; Shen J; Zhao H; Li S Mol Med Rep; 2016 Jun; 13(6):5200-6. PubMed ID: 27121462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]